Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Apremilast may help treat hair loss in alopecia areata.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Enhancing Tregs can protect against alopecia areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

The plant extract mixture improves skin health by reducing inflammation, boosting collagen, and supporting anti-aging.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.